Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset. The neurology biotech announced back in July 2025 that it was adding a new ...

Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.

Voyager Technologies is opening a new electronics manufacturing and engineering facility in Long Beach, California, expanding its presence in a region that has become a hub for space and defense ...

Voyager Technologies (NYSE:VOYG) appointed Shoshanna Moody as Chief Administrative Officer. Moody is tasked with supporting operational scale and regulatory compliance as the company expands into ...

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...